Figure 2
Figure 2. RhoA acts as a negative regulator of the FPR-mediated oxidative burst. (A-B) Superoxide production by suspension neutrophils stimulated with (A) 10 µM fMLF with and without TNFα priming (10 ng/mL) or with (B) 100 ng/mL phorbol 12-myristate 13-acetate (PMA). Arrows indicate the addition of stimulus; dark black lines indicate KO responses. (C) H2O2 production by adherent, fMLF-stimulated neutrophils. Stimulation at t = 0. Dark black lines indicate KO responses. (D) Immunoblot of p47phox and p22phox in cytosolic (C) and membrane (M) fractions derived from WT2 neutrophils stimulated with fMLF for 5 minutes and 10 ng/mL TNFα for 30 minutes, followed by fMLF for 5 minutes, or with PMA for 10 minutes. (E) Immunoblot of p47phox, p22phox, and PKCζ in membrane fractions derived from TNFα-primed or nonprimed RhoB KO2 or RhoA/B dKO neutrophils stimulated with fMLF for 5 minutes. (F) Time course of p47phox phosphorylation during fMLF stimulation of TNFα-primed WT1 neutrophils. (G) Comparison of fMLF-induced (30s) p47phox phosphorylation in RhoB KO2 or RhoA/B dKO neutrophils in the presence or absence of TNFα priming. (H) Characterization of p47phox Ser316 and Ser329 phosphorylation in WT1 neutrophils after stimulation with 10 ng/mL TNFα or 100 ng/mL PMA. (I) Erk1/2 phosphorylation in Rho-deficient suspension neutrophils stimulated with TNFα or fMLF as indicated; total Erk served as control. Means ± SEM (n = 3): (C) *P < .05, **P < .01; unpaired 2-tailed Student t test.

RhoA acts as a negative regulator of the FPR-mediated oxidative burst. (A-B) Superoxide production by suspension neutrophils stimulated with (A) 10 µM fMLF with and without TNFα priming (10 ng/mL) or with (B) 100 ng/mL phorbol 12-myristate 13-acetate (PMA). Arrows indicate the addition of stimulus; dark black lines indicate KO responses. (C) H2O2 production by adherent, fMLF-stimulated neutrophils. Stimulation at t = 0. Dark black lines indicate KO responses. (D) Immunoblot of p47phox and p22phox in cytosolic (C) and membrane (M) fractions derived from WT2 neutrophils stimulated with fMLF for 5 minutes and 10 ng/mL TNFα for 30 minutes, followed by fMLF for 5 minutes, or with PMA for 10 minutes. (E) Immunoblot of p47phox, p22phox, and PKCζ in membrane fractions derived from TNFα-primed or nonprimed RhoB KO2 or RhoA/B dKO neutrophils stimulated with fMLF for 5 minutes. (F) Time course of p47phox phosphorylation during fMLF stimulation of TNFα-primed WT1 neutrophils. (G) Comparison of fMLF-induced (30s) p47phox phosphorylation in RhoB KO2 or RhoA/B dKO neutrophils in the presence or absence of TNFα priming. (H) Characterization of p47phox Ser316 and Ser329 phosphorylation in WT1 neutrophils after stimulation with 10 ng/mL TNFα or 100 ng/mL PMA. (I) Erk1/2 phosphorylation in Rho-deficient suspension neutrophils stimulated with TNFα or fMLF as indicated; total Erk served as control. Means ± SEM (n = 3): (C) *P < .05, **P < .01; unpaired 2-tailed Student t test.

Close Modal

or Create an Account

Close Modal
Close Modal